← 回總覽

埋伏创新药,百亿资金借 ETF 入场

📅 2026-07-15 13:50 财联社 投资财经 2 分鐘 1481 字 評分: 85
创新药 ETF 板块行情 政策解读 资金流向
📌 一句话摘要 头部公募密集举牌与百亿资金借 ETF 入场推动创新药板块独立行情,产业基本面改善与政策利好支撑估值修复,但持续上涨仍需中报业绩确认。 📝 详细摘要 本文报道 2026 年 7 月创新药板块的独立上涨行情。核心驱动力来自易方达、富国、华夏等头部公募密集举牌港股创新药标的,以及港股通创新药 ETF 在 12 个交易日内净流入 117.29 亿元。产业基本面同步改善:上半年我国创新药对外授权交易额达 1100 亿美元,创新药进国家基药目录实现「零的突破」。多位基金经理看好板块价值重估,但也提示当前反弹以估值修复为主,中报业绩与海外授权分成将决定持续性。文章数据详实,信源清晰,包含

Title: 埋伏创新药,百亿资金借 ETF 入场 | BestBlogs.dev

URL Source: https://www.bestblogs.dev/article/5d7bef6695?amp%3Butm_medium=feed&%3Butm_campaign=resources&%3Bentry=rss_article_item

Published Time: 2026-07-15 13:50:00

Markdown Content: Skip to main contentAudio 2 ![Image 1: LogoBest Blogs](https://www.bestblogs.dev/ "BestBlogs.dev")

Search Ctrl+K

Change language Switch ThemeSign In

[](https://www.bestblogs.dev/en/explore/brief "Daily Brief")[](https://www.bestblogs.dev/en/explore/newsletter "Weekly Picks")[](https://www.bestblogs.dev/en/explore/topics "Topics")

[](https://www.bestblogs.dev/en/settings "Settings")[](https://www.bestblogs.dev/en/docs "Help Center")

Narrow Mode

埋伏创新药,百亿资金借 ETF 入场

Intensive stake-building by top mutual funds and billions of capital flowing into ETFs are driving a standalone rally in the innovative drug sector, supported by improving industry fundamentals and favorable policies. However, sustained upside still depends on interim report performance. HomeDiscoverSettings

查看原文 → 發佈: 2026-07-15 13:50:00 收錄: 2026-07-15 16:00:09

🤖 問 AI

針對這篇文章提問,AI 會根據文章內容回答。按 Ctrl+Enter 送出。